THDB(SH:600867) Jin Rong Jie·2025-06-10 08:18Group 1 - The core viewpoint of the news is that the China Securities Medicine and Health Dividend Index has shown positive performance, with a 6.35% increase over the past month and a 5.98% increase over the past three months, while year-to-date it has risen by 1.32% [2] - The index is designed to reflect the overall performance of high dividend yield securities in various industries, using a dividend yield weighted calculation method [2] - The index's top ten holdings include Mingde Biological (4.22%), Huate Dain (3.3%), Lingrui Pharmaceutical (3.21%), and others, indicating a diverse portfolio within the healthcare sector [2] Group 2 - The index is composed of stocks with a cash dividend yield greater than 0.5% and ranks within the top 80% of average daily trading volume over the past year, with annual adjustments made to the sample [3] - The index's holdings are primarily in traditional Chinese medicine (36.05%), chemical drugs (22.28%), and medical services (17.54%), showcasing a focus on various segments of the healthcare industry [2] - The index is maintained with specific rules regarding sample adjustments, including a limit on the proportion of changes and conditions for excluding stocks that do not meet the criteria [3]